Yuni 2022: Bayan layi biyu ko fiye na tsarin jiyya, FDA ta ba da lambar yabo ta tisagenlecleucel (Kymriah, Novartis Pharmaceuticals Corporation) da gaggawar yarda ga manya marasa lafiya tare da relapsed ko refractory follicular lymphoma (FL).T.
Agusta 2021: FDA ta ba da axicabtagene ciloleucel (Yescarta, Kite Pharma, Inc.) amincewa da gaggawa ga manya marasa lafiya tare da relapsed ko refractory follicular lymphoma (FL) bayan biyu ko fiye Lines na tsarin jiyya. A sing..